We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Zillow
ZG
$8.47B
| $1.02M | ﹤0.01% |
22,620
-10,089
| -31% | -$435K |
|
|
VMRK
1927
Vivmark Residential
VMRK
$27.1B
| $1.02M | ﹤0.01% |
14,683
+28
| +0.2% | +$1.82K |
|
|
BRSL
1928
Brightstar Lottery PLC
BRSL
$2.12B
| $1.02M | ﹤0.01% |
49,761
-16,286
| -25% | -$333K |
|
1929
Financial Institutions
FISI
$804M
| $1.01M | ﹤0.01% |
52,432
+7,496
| +17% | +$133K |
|
1930
OppFi
OPFI
$615M
| $1.01M | ﹤0.01% |
298,548
+45,069
| +18% | +$137K |
|
1931
Vitamin Cottage Natural Grocers
NGVC
$640M
| $1.01M | ﹤0.01% |
47,732
+13,227
| +38% | +$252K |
|
1932
Liquidity Services
LQDT
$1.35B
| $1.01M | ﹤0.01% |
50,600
+14,258
| +39% | +$267K |
|
1933
Unitil
UTL
$981M
| $1.01M | ﹤0.01% |
19,513
+10,134
| +108% | +$521K |
|
|
DHC
1934
Diversified Healthcare Trust
DHC
$1.94B
| $1.01M | ﹤0.01% |
331,261
-175,917
| -35% | -$446K |
|
1935
Bowman Consulting
BWMN
$737M
| $1.01M | ﹤0.01% |
+31,763
| New | +$1M |
|
1936
Compass
COMP
$8.88B
| $1M | ﹤0.01% |
278,780
+36,613
| +15% | +$134K |
|
1937
Comtech Telecommunications
CMTL
$53M
| $1M | ﹤0.01% |
330,827
+114,247
| +53% | +$271K |
|
1938
Adtran
ADTN
$645M
| $1M | ﹤0.01% |
190,520
-11,556
| -6% | -$58.9K |
|
1939
Cullinan Oncology
CGEM
$1.47B
| $1M | ﹤0.01% |
+57,361
| New | +$1.22M |
|
|
BNT
1940
Brookfield Wealth Solutions
BNT
$12.6B
| $1,000K | ﹤0.01% |
36,060
+1,800
| +5% | +$50K |
|
1941
Travelzoo
TZOO
$68.5M
| $995K | ﹤0.01% |
131,086
-29,847
| -19% | -$254K |
|
1942
Praxis Precision Medicines
PRAX
$10.3B
| $991K | ﹤0.01% |
23,966
+594
| +3% | +$28.1K |
|
1943
Photronics
PLAB
$1.74B
| $991K | ﹤0.01% |
40,172
+19,972
| +99% | +$542K |
|
1944
Independent Bank Corp
IBCP
$819M
| $989K | ﹤0.01% |
36,639
+19,608
| +115% | +$485K |
|
1945
Pegasystems
PEGA
$5.59B
| $985K | ﹤0.01% |
32,558
-75,022
| -70% | -$2.25M |
|
1946
Banc of California
BANC
$2.95B
| $982K | ﹤0.01% |
76,846
-58,971
| -43% | -$815K |
|
1947
Capital Group Dividend Value ETF
CGDV
$38.6B
| $977K | ﹤0.01% |
+29,600
| New | +$964K |
|
1948
Quanex
NX
$912M
| $976K | ﹤0.01% |
+35,284
| New | +$1.17M |
|
|
OPRA
1949
Opera Ltd
OPRA
$1.7B
| $975K | ﹤0.01% |
69,423
-185,288
| -73% | -$2.63M |
|
|
EWCZ
1950
DELISTED
European Wax Center
EWCZ
| $970K | ﹤0.01% |
97,656
-41,184
| -30% | -$468K |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.